The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Disease Management

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Disease Management


Psychiatry related information on Disease Management


High impact information on Disease Management


Biological context of Disease Management

  • CONCLUSIONS: The GeneChip TP53-sequencing assay may be feasible for routine molecular genetic diagnostics in determining the TP53 status of childhood-tumor patients and in enabling a disease management based on the genetic background of the individual [13].
  • Advances into nonadrenergic-noncholinergic novel signal transduction, specifically phosphodiesterase type-5 inhibitors, offer new opportunities for developing evidence-based treatments for this side effect and improving depression disease management outcomes [14].

Anatomical context of Disease Management


Associations of Disease Management with chemical compounds

  • Reaching National Cholesterol Education Program Goals: a managed care approach to improving hyperlipidemia disease management outcomes. Introduction [16].
  • BACKGROUND: To improve asthma disease management, the National Asthma Education Program (NAEP) Expert Panel published Guidelines for the Diagnosis and Management of Asthma in 1991 [17].
  • This body of work advanced our molecular understanding of the critical role of steroid hormones in normal and abnormal physiology and also generated a base of scientific knowledge that served to further modern hormonal therapy and disease management [18].
  • Our BCL basal/luminal signature correctly re-classified the published series of tumour samples that originally served to identify the molecular subtypes, suggesting that the identified markers should be useful for tumour classification and might represent promising targets for disease management [19].
  • RESEARCH DESIGN AND METHODS: A total of 159 African-American patients with type 2 diabetes were assessed on three domains of family life (structure/organization, world view, and emotion management) and three key dimensions of disease management (morale, management behaviors, and glucose regulation) [20].

Gene context of Disease Management


Analytical, diagnostic and therapeutic context of Disease Management


  1. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Dubinsky, M.C., Reyes, E., Ofman, J., Chiou, C.F., Wade, S., Sandborn, W.J. Am. J. Gastroenterol. (2005) [Pubmed]
  2. Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Leung, D.Y., Nicklas, R.A., Li, J.T., Bernstein, I.L., Blessing-Moore, J., Boguniewicz, M., Chapman, J.A., Khan, D.A., Lang, D., Lee, R.E., Portnoy, J.M., Schuller, D.E., Spector, S.L., Tilles, S.A. Ann. Allergy Asthma Immunol. (2004) [Pubmed]
  3. Evaluation of an enzymatic homocysteine assay for the Hitachi series chemistry analyzer. Kellogg, M.D., Parker, R., Ricupero, A., Rifai, N. Clin. Chim. Acta (2005) [Pubmed]
  4. The many faces of human growth hormone. Roehr, B. BETA bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS foundation. (2003) [Pubmed]
  5. The HCA National Disease Management Program for coronary disease detection and treatment in women. Shaw, L.J., Tarkington, L., Callister, T., Murgo, J., Simon, A., Waller, C., Battaglia, S., Mangione, N., Chambers, J., Smart, F., Mehta, S., Anderson, A., Kugelmass, A., Raggi, P., Houser, F. The American journal of managed care. (2001) [Pubmed]
  6. A feasibility study of the childhood depression medication algorithm: the Texas Children's Medication Algorithm Project (CMAP). Emslie, G.J., Hughes, C.W., Crismon, M.L., Lopez, M., Pliszka, S., Toprac, M.G., Boemer, C. Journal of the American Academy of Child and Adolescent Psychiatry. (2004) [Pubmed]
  7. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Ali, F., Laurin, M.Y., Larivière, C., Tremblay, D., Cloutier, D. The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique. (2003) [Pubmed]
  8. Diabetic nephropathy: hemodynamic basis and implications for disease management. Noth, R.H., Krolewski, A.S., Kaysen, G.A., Meyer, T.W., Schambelan, M. Ann. Intern. Med. (1989) [Pubmed]
  9. Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Mazzanti, C., Zeiger, M.A., Costouros, N.G., Umbricht, C., Westra, W.H., Smith, D., Somervell, H., Bevilacqua, G., Alexander, H.R., Libutti, S.K., Costourous, N. Cancer Res. (2004) [Pubmed]
  10. Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver. Nuwaysir, E.F., Dragan, Y.P., Jefcoate, C.R., Jordan, V.C., Pitot, H.C. Cancer Res. (1995) [Pubmed]
  11. Effects of disease management programs on functional status of patients with rheumatoid arthritis. Badamgarav, E., Croft, J.D., Hohlbauch, A., Louie, J.S., O'Dell, J., Ofman, J.J., Suarez-Almazor, M.E., Weaver, A., White, P., Katz, P. Arthritis Rheum. (2003) [Pubmed]
  12. Multiple sclerosis: modelling the future. The Multiple Sclerosis Society of Great Britain and Northern Ireland Conference: Frontiers in Science and Patient Care Disease Management. Amor, S., Layward, L., van Noort, J.M. Molecular medicine today. (1998) [Pubmed]
  13. Analysis of TP53 germline mutations in pediatric tumor patients using DNA microarray-based sequencing technology. Schaefer, K.L., Wai, D., Poremba, C., Diallo, R., Boecker, W., Dockhorn-Dworniczak, B. Med. Pediatr. Oncol. (2002) [Pubmed]
  14. Selective phosphodiesterase type-5 inhibitor treatment of serotonergic reuptake inhibitor antidepressant-associated sexual dysfunction: a review of diagnosis, treatment, and relevance. Nurnberg, H.G., Hensley, P.L. CNS spectrums. (2003) [Pubmed]
  15. Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol. Sotiriou, C.G., Cheng, J.W. The Annals of pharmacotherapy. (2000) [Pubmed]
  16. Reaching National Cholesterol Education Program Goals: a managed care approach to improving hyperlipidemia disease management outcomes. Introduction. Jacobson, T.A. Am. J. Med. (2001) [Pubmed]
  17. Compliance with national asthma management guidelines and specialty care: a health maintenance organization experience. Legorreta, A.P., Christian-Herman, J., O'Connor, R.D., Hasan, M.M., Evans, R., Leung, K.M. Arch. Intern. Med. (1998) [Pubmed]
  18. A life-long search for the molecular pathways of steroid hormone action. O'Malley, B.W. Mol. Endocrinol. (2005) [Pubmed]
  19. Gene expression profiling of breast cell lines identifies potential new basal markers. Charafe-Jauffret, E., Ginestier, C., Monville, F., Finetti, P., Adélaïde, J., Cervera, N., Fekairi, S., Xerri, L., Jacquemier, J., Birnbaum, D., Bertucci, F. Oncogene (2006) [Pubmed]
  20. Family and disease management in African-American patients with type 2 diabetes. Chesla, C.A., Fisher, L., Mullan, J.T., Skaff, M.M., Gardiner, P., Chun, K., Kanter, R. Diabetes Care (2004) [Pubmed]
  21. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis. Skoumal, M., Kolarz, G., Klingler, A. Scand. J. Rheumatol. (2003) [Pubmed]
  22. A feasibility study of the children's medication algorithm project (CMAP) algorithm for the treatment of ADHD. Pliszka, S.R., Lopez, M., Crismon, M.L., Toprac, M.G., Hughes, C.W., Emslie, G.J., Boemer, C. Journal of the American Academy of Child and Adolescent Psychiatry. (2003) [Pubmed]
  23. Predicting the costs of managing patients with chronic obstructive pulmonary disease. Mapel, D.W., McMillan, G.P., Frost, F.J., Hurley, J.S., Picchi, M.A., Lydick, E., Spencer, M.D. Respiratory medicine. (2005) [Pubmed]
  24. The clinical practice improvement (CPI) model and how it is used to examine the availability of pharmaceuticals and the utilisation of ambulatory healthcare services in HMOs. Results from the Managed Care Outcomes Project (MCOP). Horn, S.D. PharmacoEconomics. (1996) [Pubmed]
  25. Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma. Yamamoto, H., Itoh, F., Adachi, Y., Fukushima, H., Itoh, H., Sasaki, S., Hinoda, Y., Imai, K. Jpn. J. Clin. Oncol. (1999) [Pubmed]
WikiGenes - Universities